Pfizer, one of the largest drug firms in the world, has admitted to have made a major blunder lately. For the same reason, they have had to call back about a million birth control tablets. This is because there has been an error due to which the drugs have got mixed in their packaging.

As per reported information, it has got revealed that 13 drug makers and many health organizations have united with the government to eliminate 10 tropical diseases by 2020. Some of the known drug companies and health organizations which have taken the pledge with the government are Astra and Glaxo and the Bill and Melinda Gates Foundation.

Marking a grand success for the drugmaker Pfizer, its medicine Inlyta for patients suffering from advanced stages of kidney cancer has reportedly bagged a green light from the drug regulators in the United States, thereby marking a significant escalation in the efforts being made by the drug manufacturer with the intent of offsetting the sales of Lipitor.

It has been recently revealed that the drug firms, Mediation and Pfizer, have called it quits in the clinical testing for the drug dimebon. This was the crucial testing stage for the drug, and the firms deeming it useless, have done away with it.

It has been recently revealed that the Food and Drug Administration has recently approved the use of Prevnar, 13, from Pfizer. This drug is meant for treating pneumococcal conjugat, for the prevention of pneumonia.

It has been reported that Pfizer has been accused of using unauthentic practices of lowering the prices of its drug to gain domination in the generic market. For long enjoying the monopoly for its drug Lipitor, the drug manufacturer Pfizer has entered into the generic market, as the patent of its Lipitor expired last month.

In a recent report, it has been made clear that the sales of cholesterol blockbuster Lipitor have tumbled down by 50% in a single week as the market is flooded with new prescriptions for generic Lipitor. Though stern efforts were made by Lipitor maker Pfizer to ensure that patients stray with their pull, it was observed that majority of the patients had switched their preference.

Australian pharmacists’ Pharmacy Guild has again caught amidst controversies over the allegations that it received monitory aid from Pfizer, America-based pharmaceutical agency, for promoting its drugs.

Pharmacists have warned that patients suffering with various heart diseases, mental illness and other health conditions, who need an immediate medication, may be forced to wait for their drug due to obstructed deliveries from Pfizer as it recently decided to follow an industry-wide distribution system.

Pfizer is conducting an arbitrary pilot Research on Electronic Monitoring of OAB Treatment Experience (REMOTE) virtual trial in order to evaluate the safety and effectiveness of Detrol LA. The treatment is developed by the company to treat for overactive bladder (OAB).